Empowering Membrane Process Engineers: TRUSTECH Launches the Online Assistant “MEMTOOLS” In capacity planning a ...

The study will include around 200 participants aged 65 or older with BMI of at least 35 starting semaglutide therapy.

Enterprise AI platform expands across diverse industry use cases Institutional participation shows active positioning shifts in shares Earnings release reflects revenue pressure and margin challenges ...

Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...

The Judicial Service Commission’s ( JSC’s) call for application for High Court judges has stirred legal debate with experts ...

The update comes as the therapy’s regulatory application awaits a decision from the U.S. Food and Drug Administration later ...

Southeast Asian digital platform group faces sharp market momentum shift recently E commerce gaming payments ecosystem shapes ...

The issue was whether waste remediation services are taxable under GST. The Authority held that although classifiable under SAC 9994, the services qualify as pure services and are exempt. It clarified ...

Gubra today announces that a clinical trial application (CTA) for the first-in-human study of GUB-UCN2, the company's lead asset for high quality weight loss, has been submitted to the Competent Autho ...

The case examined taxability of bio-mining and waste remediation services. The Authority held that such services qualify as ...

A new review outlines design principles and applications of synthetic membraneless organelles built through liquid-liquid phase separation for use in biotechnology.

Atomic force microscopy (BioAFM) drives innovation in cosmetics and healthcare, ensuring product efficacy through precise ...